FLT3-selective PROTAC: Enhanced safety and increased synergy with Venetoclax in FLT3-ITD mutated acute myeloid leukemia
Yuxin Tan, Lilan Xin, Qian Wang, Rong Xu, Xiqin Tong, Guopeng Chen, Linlu Ma, Fuwei Yang, Hongqiang Jiang, Nan Zhang, Jinxian Wu, Xinqi Li, Xinyi Guo, Chao Wang, Hai‐Bing Zhou, Fuling Zhou
Topics & Concepts
Myeloid leukemiaVenetoclaxToxicityCancer researchMedicineFms-Like Tyrosine Kinase 3PharmacologyLeukemiaProteasomeChemistryImmunologyInternal medicineMutationBiochemistryChronic lymphocytic leukemiaGeneProtein Degradation and InhibitorsMultiple Myeloma Research and TreatmentsUbiquitin and proteasome pathways